Acute and Repeated Administration of NLX-101, a Selective Serotonin-1A Receptor Biased Agonist, Reduces Audiogenic Seizures in Developing Fmr1 Knockout Mice

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2023
Source ID
10.1016/j.neuroscience.2022.11.014

Entities

People

  • A. Newman-tancredi
  • K.a. Razak
  • M.a. Varney
  • Xin Tao

Organizations

  • National Institutes of Health
  • United States Department of Defense